keyword
https://read.qxmd.com/read/38302402/complex-architecture-of-cardiac-muscle-thick-filaments-revealed
#21
JOURNAL ARTICLE
Pradeep K Luther, Steve B Marston
Muscle contraction is orchestrated by the well-understood thin filaments and the markedly complex thick filaments. Studies by Dutta et al. and Tamborrini et al., discussed here, have unravelled the structure of the mammalian heart thick filament in exquisite near-atomic detail and pave the way for understanding physiological modulation pathways and mutation-induced dysfunction and for designing potential drugs to modify defects.
January 31, 2024: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38296675/the-structure-and-function-of-olfactory-receptors
#22
REVIEW
Chenyang Wu, Marc Xu, Junlin Dong, Wenqiang Cui, Shuguang Yuan
Olfactory receptors (ORs) form the most important chemosensory receptor family responsible for our sense of smell in the nasal olfactory epithelium. This receptor family belongs to the class A G protein-coupled receptors (GPCRs). Recent research has indicated that ORs are involved in many nonolfactory physiological processes in extranasal tissue, such as the brain, pancreas, and testes, and implies the possible role of their dysregulation in various diseases. The recently released structures of OR51E2 and consensus OR52 have also unveiled the uniqueness of ORs from other class A GPCR members...
January 30, 2024: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38290921/glymphatic-stagnated-edema-induced-by-traumatic-brain-injury
#23
JOURNAL ARTICLE
Per Kristian Eide, Geir Ringstad
Traumatic brain injury (TBI) outcomes are notably affected by brain edema. A recent report by Hussain et al. unveils a unique form, glymphatic-stagnated brain edema, that stems from impaired glymphatic and lymphatic drainage induced by noradrenergic activation. Consequently, pan-noradrenergic inhibition may emerge as an innovative treatment for TBI-related edema, challenging traditional therapeutic approaches.
January 29, 2024: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38262797/mirikizumab-omvoh%C3%A2-for-ulcerative-colitis
#24
JOURNAL ARTICLE
Alexander Hammerhøj, Theresa Louise Boye, Ebbe Langholz, Ole Haagen Nielsen
No abstract text is available yet for this article.
January 22, 2024: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38245492/revisiting-sensitivity-of-senescent-cells-to-bh3-mimetics
#25
JOURNAL ARTICLE
Nadine Martin, Anda Huna, Athanasios Tsalikis, David Bernard
B cell leukemia/lymphoma 2 (BCL2) homology domain 3 (BH3) mimetics were reported to selectively kill senescent cells and improve age-related diseases. Defining why these cells show increased sensitivity to these molecules will help to identify new pharmacological compounds with senolytic activity. Here, we discuss how recent research findings provide new clues to understand this vulnerability.
January 19, 2024: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38242748/context-dependent-role-of-sirt3-in-cancer
#26
REVIEW
Jin Zhang, Jing Ye, Shiou Zhu, Bo Han, Bo Liu
Sirtuin 3 (SIRT3), an NAD+ -dependent deacetylase, plays a key role in the modulation of metabolic reprogramming and regulation of cell death, as well as in shaping tumor phenotypes. Owing to its critical role in determining tumor-type specificity or the direction of tumor evolution, the development of small-molecule modulators of SIRT3, including inhibitors and activators, is of significant interest. In this review, we discuss recent studies on the oncogenic or tumor-suppressive functions of SIRT3, evaluate advances in SIRT3-targeted drug discovery, and present potential avenues for the design of small-molecule modulators of SIRT3 for cancer therapy...
January 18, 2024: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38216431/do-the-therapeutic-effects-of-psilocybin-involve-actions-in-the-gut
#27
REVIEW
Felicia Reed, Claire J Foldi
The psychedelic compound psilocybin has recently emerged as a therapeutic intervention for various mental health conditions. Psilocybin is a potent agonist of serotonin (5-HT) receptors (5-HTRs), which are expressed in the brain and throughout peripheral tissues, with particularly high expression in the gastrointestinal (GI) tract. However, no studies have investigated the possibility that peripheral actions of psilocybin may contribute to improvements in mental health outcomes. This is despite strong evidence for disturbed gut-brain signalling in conditions in which psilocybin is being tested clinically...
January 11, 2024: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38216430/emerging-epigenetic-insights-into-aging-mechanisms-and-interventions
#28
REVIEW
Zeming Wu, Weiqi Zhang, Jing Qu, Guang-Hui Liu
Epigenetic dysregulation emerges as a critical hallmark and driving force of aging. Although still an evolving field with much to explore, it has rapidly gained significance by providing valuable insights into the mechanisms of aging and potential therapeutic opportunities for age-related diseases. Recent years have witnessed remarkable strides in our understanding of the epigenetic landscape of aging, encompassing pivotal elements, such as DNA methylation, histone modifications, RNA modifications, and noncoding (nc) RNAs...
February 2024: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38212196/leveraging-spatial-omics-for-the-development-of-precision-sarcoma-treatments
#29
REVIEW
Cui Tu, Arutha Kulasinghe, Andrew Barbour, Fernando Souza-Fonseca-Guimaraes
Sarcomas are rare and heterogeneous cancers that arise from bone or soft tissue, and are the second most prevalent solid cancer in children and adolescents. Owing to the complex nature of pediatric sarcomas, the development of therapeutics for pediatric sarcoma has seen little progress in the past decades. Existing treatments are largely limited to chemotherapy, radiation, and surgery. Limited knowledge of the sarcoma tumor microenvironment (TME) and of well-defined target antigens in the different subtypes necessitates an alternative investigative approach to improve treatments...
January 11, 2024: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38212195/tumor-iron-homeostasis-and-immune-regulation
#30
REVIEW
Yan-Yu Zhang, Yi Han, Wen-Ning Li, Rui-Hua Xu, Huai-Qiang Ju
Abnormal iron metabolism has long been regarded as a key metabolic hallmark of cancer. As a critical cofactor, iron contributes to tumor progression by participating in various processes such as mitochondrial electron transport, gene regulation, and DNA synthesis or repair. Although the role of iron in tumor cells has been widely studied, recent studies have uncovered the interplay of iron metabolism between tumor cells and immune cells, which may affect both innate and adaptive immune responses. In this review, we discuss the current understanding of the regulatory networks of iron metabolism between cancer cells and immune cells and how they contribute to antitumor immunity, and we analyze potential therapeutics targeting iron metabolism...
January 10, 2024: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38182481/metabolite-sensing-gpcrs-in-rheumatoid-arthritis
#31
REVIEW
Xuezhi Yang, Wankang Zhang, Luping Wang, Yingjie Zhao, Wei Wei
Persistent inflammation in damaged joints results in metabolic dysregulation of the synovial microenvironment, causing pathogenic alteration of cell activity in rheumatoid arthritis (RA). Recently, the role of metabolite and metabolite-sensing G protein-coupled receptors (GPCRs) in the RA-related inflammatory immune response (IIR) has become a focus of research attention. These GPCRs participate in the progression of RA by modulating immune cell activation, migration, and inflammatory responses. Here, we discuss recent evidence implicating metabolic dysregulation in RA pathogenesis, focusing on the connection between RA-related IIR and GPCR signals originating from the synovial joint and gut...
January 4, 2024: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38160084/harnessing-deep-learning-for-enhanced-ligand-docking
#32
JOURNAL ARTICLE
Xujun Zhang, Chao Shen, Chang-Yu Hsieh, Tingjun Hou
Ligand docking (LD), a technology for predicting protein-ligand (PL)-binding conformations and strengths, plays key roles in virtual screening (VS). However, the accuracy and speed of current LD methodologies remain suboptimal. Here, we discuss how deep learning (DL) could help to bridge this gap by examining recent advancements and projecting future trends.
December 29, 2023: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38103980/spatial-pharmacology-using-mass-spectrometry-imaging
#33
REVIEW
Presha Rajbhandari, Taruna V Neelakantan, Noreen Hosny, Brent R Stockwell
The emerging and powerful field of spatial pharmacology can map the spatial distribution of drugs and their metabolites, as well as their effects on endogenous biomolecules including metabolites, lipids, proteins, peptides, and glycans, without the need for labeling. This is enabled by mass spectrometry imaging (MSI) that provides previously inaccessible information in diverse phases of drug discovery and development. We provide a perspective on how MSI technologies and computational tools can be implemented to reveal quantitative spatial drug pharmacokinetics and toxicology, tissue subtyping, and associated biomarkers...
December 15, 2023: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38103979/the-rise-of-epitranscriptomics-recent-developments-and-future-directions
#34
REVIEW
Jonas Cerneckis, Guo-Li Ming, Hongjun Song, Chuan He, Yanhong Shi
The epitranscriptomics field has undergone tremendous growth since the discovery that the RNA N6 -methyladenosine (m6 A) modification is reversible and is distributed throughout the transcriptome. Efforts to map RNA modifications transcriptome-wide and reshape the epitranscriptome in disease settings have facilitated mechanistic understanding and drug discovery in the field. In this review we discuss recent advancements in RNA modification detection methods and consider how these developments can be applied to gain novel insights into the epitranscriptome...
December 15, 2023: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38102020/pharmacological-targets-at-the-lysosomal-autophagy-nlrp3-inflammasome-crossroads
#35
REVIEW
Srinivasa Reddy Bonam, Dylan Mastrippolito, Philippe Georgel, Sylviane Muller
Many aspects of cell homeostasis and integrity are maintained by the nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) inflammasome. The NLRP3 oligomeric protein complex assembles in response to exogenous and endogenous danger signals. This inflammasome has also been implicated in the pathogenesis of a range of disease conditions, particularly chronic inflammatory diseases. Given that NLRP3 modulates autophagy, which is also a key regulator of inflammasome activity, excessive inflammation may be controlled by targeting this intersecting pathway...
December 14, 2023: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38097426/prevalence-recovery-and-factors-associated-with-dysphagia-in-an-older-critically-ill-trauma-cohort-a-cross-sectional-study
#36
JOURNAL ARTICLE
Amy Freeman-Sanderson, Janae Crisp, Carol L Hodgson, Anne E Holland, Meg Harrold, Terry Chan, Claire J Tipping
BACKGROUND: Patients admitted to the intensive care unit (ICU) following trauma often have multiple injuries, which can lead to disordered swallowing, dysphagia. The prevalence of dysphagia in trauma populations ranges between 4.2% and 86%; however, clinical and associated longitudinal health outcomes and patient-reported quality of life are unknown. OBJECTIVES: The objective of this study was to compare hospital and clinical outcomes for older critically ill trauma patients diagnosed with and without dysphagia up to 12 months after hospital admission...
December 13, 2023: Australian Critical Care: Official Journal of the Confederation of Australian Critical Care Nurses
https://read.qxmd.com/read/38088863/spectral-fingerprinting-of-cellular-lipid-droplets-using-stimulated-raman-scattering-microscopy-and-chemometric-analysis
#37
JOURNAL ARTICLE
Aurélie Rensonnet, William J Tipping, Cedric Malherbe, Karen Faulds, Gauthier Eppe, Duncan Graham
Hyperspectral stimulated Raman scattering (SRS) microscopy is a powerful method for direct visualisation and compositional analysis of cellular lipid droplets. Here we report the application of spectral phasor analysis as a convenient method for the segmentation of lipid droplets using the hyperspectral SRS spectrum in the high wavenumber and fingerprint region of the spectrum. Spectral phasor analysis was shown to discriminate six fatty acids based on vibrational spectroscopic features in solution. The methodology was then applied to studying fatty acid metabolism and storage in a mammalian cancer cell model and during drug-induced steatosis in a hepatocellular carcinoma cell model...
December 13, 2023: Analyst
https://read.qxmd.com/read/38072723/computational-and-artificial-intelligence-based-approaches-for-drug-metabolism-and-transport-prediction
#38
REVIEW
Balint Dudas, Maria A Miteva
Drug metabolism and transport, orchestrated by drug-metabolizing enzymes (DMEs) and drug transporters (DTs), are implicated in drug-drug interactions (DDIs) and adverse drug reactions (ADRs). Reliable and precise predictions of DDIs and ADRs are critical in the early stages of drug development to reduce the rate of drug candidate failure. A variety of experimental and computational technologies have been developed to predict DDIs and ADRs. Recent artificial intelligence (AI) approaches offer new opportunities for better predicting and understanding the complex processes related to drug metabolism and transport...
December 9, 2023: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38071088/biomarkers-and-targeted-therapy-for-cancer-stem-cells
#39
REVIEW
Yusheng Liu, Hua Wang
Cancer stem cells (CSCs) are a small subpopulation of cancer cells with capabilities of self-renewal, differentiation, and tumorigenicity, and play a critical role in driving tumor heterogeneity that evolves insensitivity to therapeutics. For these reasons, extensive efforts have been made to identify and target CSCs to potentially improve the antitumor efficacy of therapeutics. While progress has been made to uncover certain CSC-associated biomarkers, the identification of CSC-specific markers, especially the targetable ones, remains a significant challenge...
December 8, 2023: Trends in Pharmacological Sciences
https://read.qxmd.com/read/38065777/ppar-agonists-for-the-treatment-of-neuroinflammatory-diseases
#40
REVIEW
Celene Titus, Md Tozammel Hoque, Reina Bendayan
Peroxisome proliferator-activated receptors [PPARs; PPARα, PPARβ/δ (also known as PPARδ), and PPARγ] widely recognized for their important role in glucose/lipid homeostasis, have recently received significant attention due to their additional anti-inflammatory and neuroprotective effects. Several newly developed PPAR agonists have shown high selectivity for specific PPAR isoforms in vitro and in vivo, offering the potential to achieve desired therapeutic outcomes while reducing the risk of adverse effects...
December 7, 2023: Trends in Pharmacological Sciences
keyword
keyword
45143
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.